The SLCO1B1*5 genetic variant is associated with statin-induced side effects (Q36158024)

12 August 2017

The SLCO1B1*5 genetic variant is associated with statin-induced side effects (English)

1 reference

12 August 2017

Deepak Voora

1

1 reference

12 August 2017

Svati H Shah

2

1 reference

12 August 2017

Ivan Spasojevic

3

1 reference

12 August 2017

Shazia Ali

4

1 reference

12 August 2017

Carol R Reed

5

1 reference

12 August 2017

Benjamin A Salisbury

6

1 reference

12 August 2017

Geoffrey S Ginsburg

7

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

Journal of the American College of Cardiology

12 August 2017

1 reference

12 August 2017

54

1 reference

12 August 2017

17

1 reference

12 August 2017

1609-1616

1 reference

Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417133

Von Willebrand factor, type 2 diabetes mellitus, and risk of cardiovascular disease: the framingham offspring study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417133

SLCO1B1 variants and statin-induced myopathy--a genomewide study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417133

Toward "pain-free" statin prescribing: clinical algorithm for diagnosis and management of myalgia.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417133

Statin induced myotoxicity: the lactone forms are more potent than the acid forms in human skeletal muscle cells in vitro

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417133

Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417133

Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417133

Statin safety: an overview and assessment of the data--2005.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417133

Statins, cardiovascular disease, and drug safety

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417133

Clinical implications of pharmacogenomics of statin treatment

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417133

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417133

Haploview: analysis and visualization of LD and haplotype maps

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417133

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417133

Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417133

Functional role of Ile264 in CYP2C8: mutations affect haem incorporation and catalytic activity.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417133

Statin safety: an assessment using an administrative claims database.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417133

Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417133

Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417133

CYP2D6*4 polymorphism is associated with statin-induced muscle effects

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417133

Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin

5 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417133

SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid

5 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417133

SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin

5 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3417133

Cardiovascular disease and steroid hormone contraception. Report of a WHO Scientific Group

5 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19833260

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

An assessment of statin safety by muscle experts

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19833260

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19833260

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.JACC.2009.04.053

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

19833260

1 reference